Table 3 Post left ventricular device implant events, costs, and antibiotic consumption
Uninfected N = 43 | Infected N = 67 | P | Excess | |
|---|---|---|---|---|
Device Trauma (%) | 16.3 | 40.3 | 0.008 | |
Mean no. 30d readmissions / patient (SD) | 1.4 (0.7) | 2.4 (1.7) | 0.0004 | |
Mean no. 90d readmissions/patient (SD) | 1.5 (0.9) | 3.3 (2.5) | 0.0001 | |
Total No. post implant readmissions | 50 | 231 | ||
Mean LOS/admission (SD) | 7.1 (9.4) | 9.6 (12.9) | 0.19 | 2.5 days |
Total days / study period | 355 | 2,218 | 1863 | |
Mean Total days/person | 8.3 (9.4) | 33.1 (12.9) | 0.0001 | 24.8 |
Driveline relocation or explanation | 0 | 8 (12%) | ||
Exploration of chest cavity/mediastinum | 2 | 2 | 0.64 | |
Neurologic Dysfunction w CNS Injury | 4 (8%) | 9 (13%) | 0.41 | |
Major Bleeding | 8 (19%) | 16 (24%) | 0.53 | |
Mortality | 10 (23%) | 9 (13%) | 0.17 | |
Median days from implant to death (IQR) | 38.5 (26–662) | 616 (179–889) | 0.06 | |
Non-LVAD infection | 23 | 42 | 0.30 | |
Direct Costs | ||||
Labor | $11,745 | $12,551 | ||
Supplies, Pharmacy, Other | $5,274 | $5,640 | ||
Total /admission | $17.019 | $18,191 | $1,172 | |
Total for study period | $850,950 | $4,202,121 | $3,351,171 | |
Mean total / person | $19,790 | $62,718 | $42,928 | |
Antibiotic Consumption | ||||
No infection of any type (n = 20) | Non-LVAD Infection | LVAD infect. | ||
Total Days of Therapy^ | 0 | 253 | 3960 | 4,213 |
Mean unjustified Days^ | 0 | 3 | 13 | |